EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy

European Journal of Neurology - Tập 17 Số 12 - Trang 1408-1418 - 2010
R J Galvin1, Geir Bråthen, Andrei Ivashynka, Matti Hillbom, Radu Tănăsescu, Maurizio Leone
1Department of Neurology, Cork University Hospital, Wilton, Cork, Ireland

Tóm tắt

Background:  Although Wernicke encephalopathy (WE) is a preventable and treatable disease it still often remains undiagnosed during life.

Objectives:  To create practical guidelines for diagnosis, management and prevention of the disease.

Methods:  We searched MEDLINE, EMBASE, LILACS, Cochrane Library.

Conclusions and recommendations: 

 The clinical diagnosis of WE should take into account the different presentations of clinical signs between alcoholics and non alcoholics (Recommendation Level C); although prevalence is higher in alcoholics, WE should be suspected in all clinical conditions which could lead to thiamine deficiency (good practice point – GPP).

 The clinical diagnosis of WE in alcoholics requires two of the following four signs; (i) dietary deficiencies (ii) eye signs, (iii) cerebellar dysfunction, and (iv) either an altered mental state or mild memory impairment (Level B).

 Total thiamine in blood sample should be measured immediately before its administration (GPP).

 MRI should be used to support the diagnosis of acute WE both in alcoholics and non alcoholics (Level B).

 Thiamine is indicated for the treatment of suspected or manifest WE. It should be given, before any carbohydrate, 200 mg thrice daily, preferably intravenously (Level C).

 The overall safety of thiamine is very good (Level B).

 After bariatric surgery we recommend follow‐up of thiamine status for at least 6 months (Level B) and parenteral thiamine supplementation (GPP).

 Parenteral thiamine should be given to all at‐risk subjects admitted to the Emergency Room (GPP).

 Patients dying from symptoms suggesting WE should have an autopsy (GPP).

Từ khóa


Tài liệu tham khảo

10.1142/S0192415X04002594

10.1093/alcalc/agm144

WernickeC.Lehrbuch der Gehirnkrankheiten fur Aerzte und Studirende.1881;229–242.

10.1007/BF02229734

10.1111/j.1468-1331.2004.00867.x

10.1097/SLA.0b013e3181884308

10.1212/01.wnl.0000256812.29648.86

10.1097/01.ogx.0000206336.08794.65

10.1136/jnnp.62.1.51

10.1016/S0140-6736(84)92918-0

10.1016/S0140-6736(99)01410-5

10.1016/S0002-8223(95)00148-4

10.1016/S0002-9343(99)80349-0

10.1136/jnnp.37.8.959

10.1016/0378-4347(91)80075-N

10.1373/clinchem.2007.099077

10.1056/NEJMc0809100

10.1007/BF00315284

10.2214/ajr.171.4.9763009

10.2214/AJR.07.3959

10.1111/j.1530-0277.2001.tb02134.x

10.1002/14651858.CD004033.pub2

10.1093/ajcn/66.4.925

10.1016/j.annemergmed.2007.02.007

10.1093/alcalc/37.6.513

10.1016/S1474-4422(07)70104-7

10.1093/alcalc/agh249

10.3177/jnsv.22.Supplement_63

Thomson AD, 1983, Ethanol, thiamine and brain damage, Alcohol Alcohol, 18, 27

Brown LM, 1983, Efficacy of vitamin supplementation in chronic alcoholics undergoing detoxification, Alcohol Alcohol, 18, 157

10.1016/S0196-0644(89)80215-X

10.1093/alcalc/agh250

10.1111/j.1468-1331.2006.01530.x

10.1079/PHN19980018

10.1093/ajcn/33.12.2750

10.1111/j.1468-1331.2009.02917.x

10.1111/j.1468-1331.2006.01531.x

10.1001/archneur.1961.00450110040005

Jellinger K, 1976, Neuropathological aspects of dementias resulting from abnormal blood and cerebrospinal fluid dynamics, Acta Neurol Belg, 76, 83

Victor M, 1971, The Wernicke‐Korsakoff syndrome. A clinical and pathological study of 245 patients, 82 with post‐mortem examinations, Contemp Neurol Ser, 7, 1

10.1016/0022-510X(82)90145-9

10.1136/jnnp.42.3.226

10.1136/jnnp.46.7.593

10.1093/brain/111.4.843

10.1136/jnnp.52.2.282

10.1016/0022-510X(89)90095-6

Pollak KH, 1989, Alcoholism and morphologic findings of the nervous system in autopsy cases, Psychiatr Neurol Med Psychol (Leipz), 41, 664

10.1007/BF01369809

10.1136/pgmj.67.793.978

Riethdorf L, 1991, Die Alkoholenzephalopathien im Obduktionsgut, Zentralbl Pathol, 137, 48

10.1111/j.1699-0463.1991.tb01255.x

10.1590/S0004-282X1992000300012

Boldorini R, 1992, Wernicke’s encephalopathy: occurrence and pathological aspects in a series of 400 AIDS patients, Acta Biomed Ateneo Parmense, 63, 43

10.1007/BF01991779

10.1111/j.1530-0277.1999.tb04053.x

10.5694/j.1326-5377.1998.tb139081.x

10.1038/sj.bmt.1702140

10.1007/s00415-009-5038-1

10.1097/00000441-200202000-00010

10.1159/000174951

10.1212/WNL.19.11.1135

10.1136/jnnp.49.4.341

10.1038/sj.bmt.1700892

10.2214/ajr.155.6.2122685

10.1111/j.1552-6569.2001.tb00070.x

Varnet O, 2002, Wernicke‐Korsakoff syndrome: diagnostic contribution of magnetic resonance imaging, Rev Neurol (Paris), 158, 1181

Weidauer S, 2003, Wernicke encephalopathy: MR findings and clinical presentation, Eur Radiol, 13, 1001, 10.1007/s00330-002-1624-7

10.1016/S0735-6757(03)00094-9

10.1007/s00234-003-1043-8

White ML, 2005, MR imaging with diffusion‐weighted imaging in acute and chronic Wernicke encephalopathy, AJNR Am J Neuroradiol, 26, 2306

10.3174/ajnr.A1280

10.1159/000008226

10.1159/000052086

Zhong C, 2005, MR Imaging of nonalcoholic Wernicke encephalopathy: a follow‐up study, AJNR Am J Neuroradiol, 26, 2301

10.3748/wjg.v12.i26.4224

10.1016/j.ejrad.2005.07.002

10.3174/ajnr.A0827

Kirbas D, 2008, The impact of prolonged hunger strike: clinical and laboratory aspects of twenty‐five hunger strikers, Ideggyogy Sz, 61, 317

10.1007/s002340050741

10.1016/j.nut.2008.08.003